Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study

This study has been withdrawn prior to enrollment.
(Study never started.)
Sponsor:
Collaborator:
3M
Information provided by:
University of Alberta
ClinicalTrials.gov Identifier:
NCT00230373
First received: September 28, 2005
Last updated: April 22, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: June 2007
  Estimated Primary Completion Date: No date given